Dendrite receives order to expand Regional Lung Cancer Registry to the whole of Wales
Dendrite Clinical Systems has received an order from NHS Wales to expand the successful Regional Lung Cancer Registry in North Wales to cover the whole of the country, established the Welsh National Lung Cancer Pleural Nodules Registry. The registry is designed for health professionals to collect, view and use real-time data about their patients with pleural disease.
This secure, web-based registry enables valuable real-world data to be gathered from everyday clinical settings about patient outcomes in malignant and non-malignant disease. Utilising Dendrite’s “Intellect Web” software, the registry allows respiratory clinicians across Wales to enter patient data online, using a range of modern html-5 compatible web browsers, without the need to install additional software or perform any complex system configurations.
In addition, the registry will assess the impact of pleural interventions including thoracoscopy and the use of indwelling pleural catheters, as well as recording and analysing individual operator performance.
“We are delighted that NHS has expanded this very important registry throughout the whole of Wales,” said Dr Peter Walton, Managing Director of Dendrite Clinical Systems. “We hope the expansion of the registry will prove be an invaluable tool for all clinical teams involved in the care of this group of patients, and overtime, help to improve the outcomes for patients with this malignant and non-malignant disease.”
Dendrite Clinical Systems is delighted to report that our Managing Director, Dr Peter Walton, has published a chapter discussing the value of clinical registries in new publication on Laparoscopic Sleeve Gastrectomy (LSG). In his Chapter, Dr Peter Walton outlines value of national bariatric registries and their capability to deliver evidence on a global basis, as well as providing some practical perspectives on best practice when setting out to start a national registry and how to keep a good registry going.
Dendrite Clinical Systems and the Institute for Health Research (IGES) in Berlin, Germany, have initiated the Outpatient Treatment of COVID-19 Infections (ABC-19) study, to record data on the treatment of COVID-19 patients and discover more about the outpatient course of the disease, the individual risk factors of patients that contribute to severe COVID-19 courses and the procedures of general practitioners (GPs).
Researchers at the University College London and University College London Hospitals NHS Foundation Trust), London, UK, have reported that the vast majority of participants with new onset loss of smell were positive for COVID19, and this acute loss of sense of smell needs to be considered globally as a criterion for self-isolation, testing and contact tracing in order to contain the spread of COVID-19.
Dendrite Clinical Systems’ innovative “Intellect Web” software has been chosen by an international group of 17 leading diabetes experts from the multidisciplinary Diabetes Surgery Summit (DSS), as the platform on which the CoviDiab project will establish a Global Registry to collect new cases of diabetes in patients with COVID-19.


